|
× |
 |
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF |
$40.00 |
|
$40.00 |
|
× |
|
Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium PDF |
$40.00 |
|
$40.00 |
|
× |
|
Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Dermatology Precautions and Slower Titration Yield Low Incidence of Lamotrigine Treatment-Emergent Rash PDF |
$40.00 |
|
$40.00 |
|
× |
|
Non-HDL Cholesterol: A New Endpoint in Cardio-Metabolic Health Monitoring PDF |
$40.00 |
|
$40.00 |
|
|